Abstract
Background and aim Motor neuron diseases (MND) are heterogeneous and complex neurodegenerative disorders. Biomarkers could facilitate early diagnosis, prognosis determination, and patient stratification. Among the most studied biomarkers are neurofilaments, with peripherin (PRPH), a specific type predominantly expressed in peripheral nervous system neurons, gaining attention. To date, no studies have evaluated PRPH levels in human plasma.
Methods sandwich-ELISA was used to quantify plasma peripherin from 120 MND (100 ALS, 4 PMA, 15 PLS), 73 MND-mimics (including myelopathy, radiculopathy, axonal neuropathies, Hirayama disease, IBM, benign fasciculation syndrome, functional syndrome, myasthenia, post-polio syndrome) and 38 healthy-controls (HCs). Plasma was collected at the time of diagnosis or some months earlier. 41 ALS were evaluated longitudinally. ALSFRSr, MRC, spirometry, genetic tests, disease progression rate (PR), blood examinations, and neuropsychological tests were performed. Statistical analyses included Kruskal-Wallis, Mann-Whitney, Cox-regression, and Kaplan-Meier curves.
Results PRPH plasma levels is different between groups (p<0.0001); Bonferroni’s correction shows higher PRPH in MND compared to MND-mimics and HCs. Comparing PLS with HSP PRPH resulted to be higher (p=0.0001). Differences are confirmed co-variating for age and sex. ROC curve shows a good capability of PRPH to discriminate ALS from MND mimics (AUC= 0.85).
PRPH levels correlated directly with ALSFRSr, and with lower body involvement while inversely with PR. Higher PRPH levels were associated with survival advantages.
Discussion Plasma PRPH levels are elevated in MND, particularly ALS, from the early disease stages, distinguishing MND from mimics and correlating with clinical parameters and survival. Further multicentre studies incorporating additional biomarkers are required to refine the diagnostic and prognostic utility of PRPH in MND.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval was granted by the Turin ALS Centre Ethics Committee (Comitato Etico Azienda Ospedaliero-Universitaria Cittá della Salute e della Scienza, Torino) (n 0011613, 03/02/2020), and all participants provided written informed consent.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos